
Reverie Labs
Reverie Labs is a YC Winter 2018 (W18) company. Based in Cambridge, MA, USA. Team of 29.
About Reverie Labs
Summary
Reverie Labs develops brain-penetrant cancer therapies using machine learning to drive small-molecule drug discovery. The company applies AI to design and optimize compounds that can cross the blood-brain barrier, targeting cancers that are difficult to treat with conventional drugs. This replaces the slower, largely manual medicinal chemistry iteration that traditional drug discovery relies on.
From the Y Combinator listing
Engineering next-generation, brain-penetrant cancer therapies.
Reverie Labs is engineering next-generation, brain-penetrant cancer therapies.
Facts
- Healthcare / Healthcare -> Therapeutics
- Cambridge, MA, USA
- 29
- Inactive
- Early
Founders (3)
- Connor Duffy
- Jonah Kallenbach
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works